Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.

NEWS & EVENTS

Olon on Pharma Horizon Magazine

October 2017
Not just a telling story... Click the image to read the full article
June 9th, 2017 - OLON acquired RICERCA

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA)Acquisition strengthens service offering of global CDMO and Gener...
READ MORE
CPhI Worldwide – Visit us at Booth # 80G51

Frankfurt, 24-26 October 2017
If you need information, speak to one our experts.

FOCUS ON

Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.